Forskolin is a potent activator of adenylate cyclase, leading to a cascade of intracellular events by increasing cAMP, a critical secondary messenger involved in the regulation of numerous biological processes. This elevation of cAMP can enhance protein kinase A (PKA) activity, which is known to phosphorylate a myriad of proteins, potentially altering the function and activity of proteins such as C16orf71, if it were a substrate for PKA. Simultaneously, ionomycin, a calcium ionophore, can dramatically change intracellular calcium concentrations, acting as a robust activator of calcium-dependent signaling pathways. The surge in calcium ions might activate various calmodulins and calcium-dependent kinases, which are integral to numerous cellular functions including the modulation of protein activities. This modulation could extend to proteins like C16orf71, influencing their state of activation and their role within the cell.
Meanwhile, agents like Phorbol 12-myristate 13-acetate (PMA) directly stimulate protein kinase C (PKC), a family of kinases involved in controlling the function of other proteins through phosphorylation. PKC activation could result in phosphorylation of a broad spectrum of proteins, possibly including C16orf71, thereby affecting its activity. Hormonal activators like insulin engage the PI3K/AKT signaling pathway, a critical route for regulating functions such as glucose uptake, metabolism, and cell survival. Activation of this pathway could lead to the phosphorylation and subsequent modulation of a range of proteins, potentially influencing the activity of proteins similar to C16orf71. Epidermal Growth Factor (EGF), through binding to its receptor (EGFR), initiates a downstream signaling cascade that results in protein phosphorylation and modulation of activity. Such signaling cascades are essential for cell growth and proliferation, and their influence might extend to the function of proteins like C16orf71. In the same vein, Lithium chloride, an inhibitor of GSK-3β, indirectly modulates the activity of the Wnt signaling pathway. This modulation can lead to alterations in the phosphorylation state and activity of associated proteins, which could include C16orf71, affecting its stability and function within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium concentration, which could activate calmodulin-dependent kinases potentially influencing C16orf71 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which may lead to phosphorylation and activation of proteins, including C16orf71, if it is a substrate. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Activates the PI3K/AKT pathway, which could result in the activation of downstream proteins, potentially including C16orf71. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, leading to the activation of Wnt signaling pathway proteins, which could influence C16orf71 activity. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Inhibits TGF-β signaling, which could lead to upregulation or activation of proteins within this pathway, potentially affecting C16orf71. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK1, potentially altering cytoskeleton dynamics and possibly affecting proteins involved in related signaling, such as C16orf71. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK, which could lead to altered MAPK/ERK pathway activity and, consequently, protein activation states, perhaps including C16orf71. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, altering AKT signaling and potentially affecting downstream proteins, including C16orf71. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which can affect protein synthesis and activity, potentially including C16orf71. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
Inhibits gamma-secretase, leading to modulation of Notch signaling, which could influence the activity of various proteins, potentially including C16orf71. | ||||||